The 5 vaccine-preventable groups of bacterial meningitis in the United States are A, C, W, Y, and B. The meningitis vaccine your child may have received when they were younger didn’t cover meningitis B, since a vaccine for meningitis B wasn’t available until late 2014. To help protect against the 5 vaccine-preventable groups of meningitis, two different types of vaccines are needed, one for MenACWY and one for MenB.

BEXSERO is a vaccine indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B and is approved for use in individuals 10 through 25 years of age.

BEXSERO is the only meningitis B vaccine that can be completed in as fast as 1 month with just 2 doses.

About 1 in 10 young adults carry the bacteria that cause meningitis B – usually without symptoms – and may spread it to others. Also, the disease can spread from person to person through close contact, such as coughing or kissing, or living in close quarters. It’s important to remember that meningitis B is unpredictable. It can progress quickly and can sometimes be fatal within 24 hours. About 1 in 10 people infected with meningitis B will die.

A vaccine for meningitis B wasn’t available until late 2014; that’s why most 16- to 23-year-olds haven’t been vaccinated against this type of meningitis.

It’s important to receive both doses of BEXSERO at least one month apart.

Sign up for 2nd Dose Reminders and we’ll help you remember when it’s time to schedule your next appointment and get the 2nd dose.

No, the vaccine is designed to help prevent meningitis B and cannot cause meningococcal disease.

Important Safety Information
About BEXSERO

  • Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
  • The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions

Important Safety Information About BEXSEROImportant Safety Information
About BEXSERO

  • Anyone who is allergic to the ingredients of BEXSERO or who had a severe allergic reaction after a previous dose should not receive BEXSERO
  • The tip caps of the prefilled syringes contain natural rubber latex, which may cause allergic reactions
  • Tell your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding
  • Fainting can happen after getting BEXSERO. Sometimes people who faint can fall and hurt themselves. For this reason, your healthcare provider may ask you to sit or lie down for 15 minutes after receiving BEXSERO
  • The most common side effects are pain, redness or hardness at the injection site; muscle pain; fatigue; headache; nausea; and joint pain
  • Some individuals with weakened immune systems may have reduced immune responses to BEXSERO
  • Individuals with certain complement deficiencies and individuals receiving treatment that inhibits terminal complement activation (for example, eculizumab) are at increased risk for invasive disease caused by Neisseria meningitidis group B even after being vaccinated with BEXSERO
  • Vaccination with BEXSERO may not result in protection in all vaccine recipients
  • Ask your healthcare provider about the risks and benefits of BEXSERO. Only a healthcare provider can decide if BEXSERO is right for you or your child